Correlation Between Incannex Healthcare and Collegium Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Incannex Healthcare and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incannex Healthcare and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incannex Healthcare Ltd and Collegium Pharmaceutical, you can compare the effects of market volatilities on Incannex Healthcare and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incannex Healthcare with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incannex Healthcare and Collegium Pharmaceutical.

Diversification Opportunities for Incannex Healthcare and Collegium Pharmaceutical

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Incannex and Collegium is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Incannex Healthcare Ltd and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Incannex Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incannex Healthcare Ltd are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Incannex Healthcare i.e., Incannex Healthcare and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Incannex Healthcare and Collegium Pharmaceutical

Given the investment horizon of 90 days Incannex Healthcare Ltd is expected to generate 13.6 times more return on investment than Collegium Pharmaceutical. However, Incannex Healthcare is 13.6 times more volatile than Collegium Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about 0.03 per unit of risk. If you would invest  272.00  in Incannex Healthcare Ltd on October 9, 2024 and sell it today you would lose (81.00) from holding Incannex Healthcare Ltd or give up 29.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Incannex Healthcare Ltd  vs.  Collegium Pharmaceutical

 Performance 
       Timeline  
Incannex Healthcare 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Incannex Healthcare Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Incannex Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Incannex Healthcare and Collegium Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Incannex Healthcare and Collegium Pharmaceutical

The main advantage of trading using opposite Incannex Healthcare and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incannex Healthcare position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.
The idea behind Incannex Healthcare Ltd and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements